We are live on ! Find out more
TENX icon

Tenax Therapeutics
TENX

15 hedge funds and large institutions have $6.24M invested in Tenax Therapeutics in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more capital invested

Capital invested by funds: $2.08M → $6.24M (+$4.16M)

0% more ownership

Funds ownership: 0.02% → 0.02% (+0%)

0% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 3

12% less funds holding

Funds holding: 17 → 15 (-2)

40% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 5

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
AC
Armistice Capital
New York
+$2.69M
2
Two Sigma Advisers
Two Sigma Advisers
New York
+$81.1K
3
Vanguard Group
Vanguard Group
Pennsylvania
+$36.3K
4
Northern Trust
Northern Trust
Illinois
+$8.54K
5
TRCT
Tower Research Capital (TRC)
New York
+$6.4K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$248K
2
WS
Wedbush Securities
California
-$47K
3
Two Sigma Investments
Two Sigma Investments
New York
-$36.3K
4
VF
Virtu Financial
New York
-$32K
5
Goldman Sachs
Goldman Sachs
New York
-$20K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Armistice Capital
New York
$3.11M +$2.69M +1,262 New
BlackRock
2
BlackRock
New York
$923K – – –
Renaissance Technologies
3
Renaissance Technologies
New York
$812K -$248K -116 -26%
TCM
4
Tang Capital Management
California
$708K – – –
Two Sigma Investments
5
Two Sigma Investments
New York
$196K -$36.3K -17 -18%
Two Sigma Advisers
6
Two Sigma Advisers
New York
$156K +$81.1K +38 +146%
FWP
7
FAS Wealth Partners
Kansas
$90K – – –
Vanguard Group
8
Vanguard Group
Pennsylvania
$61K +$36.3K +17 +213%
Geode Capital Management
9
Geode Capital Management
Massachusetts
$50K – – –
Ameriprise
10
Ameriprise
Minnesota
$46K – – –
VF
11
Virtu Financial
New York
$33K -$32K -15 -54%
Northern Trust
12
Northern Trust
Illinois
$26K +$8.54K +4 +57%
William Blair & Company
13
William Blair & Company
Illinois
$15K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$8K +$6.4K +3 New
BCV
15
Banque Cantonale Vaudoise
Switzerland
$2K +$2.13K +1 New
WS
16
Wedbush Securities
California
– -$47K -33 Closed
Goldman Sachs
17
Goldman Sachs
New York
– -$20K -14 Closed
Citadel Advisors
18
Citadel Advisors
Florida
– -$18K -13 Closed
HF
19
HRT Financial
New York
– -$18K -13 Closed
HWA
20
HCR Wealth Advisors
California
– -$14K -10 Closed

TENX Hedge Fund Activity: Q3 2020 in Review

15 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q3 2020, worth a combined $6.24M — up 200% from $2.08M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TENX and 3 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 3 added.

The largest buyer was Armistice Capital, opening a new position worth an estimated $2.69M. The largest seller was Renaissance Technologies, cutting an estimated $248K.

  • 15 institutional investors held Tenax Therapeutics (TENX) as of Q3 2020, down from 17 in Q2 2020.
  • Funds reported $6.24M of Tenax Therapeutics stock for Q3 2020, up 200% quarter-over-quarter.
  • 3 funds opened new Tenax Therapeutics positions in Q3 2020 and 5 closed out, a net change of -2 holders.
  • The largest Tenax Therapeutics buyer in Q3 2020 was Armistice Capital, an estimated $2.69M added.
  • The largest Tenax Therapeutics seller in Q3 2020 was Renaissance Technologies, an estimated $248K sold.

Based on aggregated 13F filings for Q3 2020.